skip to content

Khondrion. Fully operational since 2012 and located in Nijmegen, The Netherlands, Khondrion primarily focuses on the development of innovative therapies for inherited mitochondrial diseases, including Leigh Disease, MELAS, Leber’s Hereditary Optic Neuropathy and other Respiratory Chain / Oxidative Phosphorylation disorders. The company's focus is on its own product development programmes. Khondrion has extensive experience in mitochondrial medicine, unique quantitative live-cell imaging technologies and in-depth characterised patients-derived cell panels. In this scope, the company developed a portfolio of pre-clinical drug candidates, among them the frontrunner KH176 is currently under clinical evaluation. Khondrion will also offer a possibility of short visits/secondments for the ESRs in order to conduct parts of their research or learn specific methodologies. A high-end course in advanced methodologies for analysis of mitochondrial function with the title “Drug Development for modulators of mitochondrial dysfunction” will be organized by Khondrion with a direct interest in mitochondrial pathophysiology.

http://www.khondrion.com/

 

 

Partner Organizations:

 

 

Oroboros provides the worldwide leading concept and technology for highresolution respirometry applied to the functional diagnosis of mitochondrial defects by simultaneous monitoring metabolic parameters in small samples of biopsies, cultured cells and isolated mitochondria. Oroboros will also offer a possibility of short visits/secondments for the ESRs in order to conduct parts of their research or learn specific methodologies. A high-end course in advanced methodologies for analysis of mitochondrial function with the title “High-Resolution Respirometry (HRR) and O2k-Fluorometry” will be organized by Oroboros with a direct interest in mitochondrial pathophysiology.

http://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS

 

 

CMMC - Center for Molecular Medicine Cologne. CMMC is a joint enterprise of the Faculty of Medicine, and the Faculty of Mathematics and Natural Sciences at the University of Cologne. It offers its members a platform to exploit synergies in the exploration of molecular and cellular mechanisms of human diseases and access to funding in competitive funding programs. CMMC manages the scientific exchange but also takes responsibility for the project management of third-party funded projects in the Faculties. CMMC will offer two ESRs short stay visits (max 3 months each) to gather experiences in large network maintenance and funding program management. Students will organize seminars and support scientists in exchanges views and ideas. They will also be introduced in the controlling of third-party funded projects, organization of call for proposals and selection procedures.

http://www.cmmc-uni-koeln.de/home/

 

 

Landesclusteragentur BIO.NRW. BIO.NRW is an agency with 8 FTE funded by the region of North Rhine- Westphalia to centralize public support and advice for the biotech and life science sector. BIO.NRW maintains links and exchange among the regional corporate, public and academic partners and stimulates investments and new ventures. BIO.NRW offers academic institutions support in bringing ideas to market and preparing its students for a non-academic career. Annual highlights are the business angel congress gathering Europe's heaviest private equity investors and an annual 2-day student convention in soccer stadiums to prepare students’ transit to corporate careers. BIO.NRW will offer access to the student convention, usually be held in July, and will offer a 1-day workshop about the requirements of the lifescience employment market and the transition from academia to business. Additionally one ESR will be offered short stay visits (max 3 months each) in the Heidelberg offices to learn the business perspective on technology transfer.

http://www.bio.nrw.de/

 

 

German EIT Health GmbH (EIT-Health): EIT-Health is a small sized company with 6 FTE located with office space in Heidelberg and Mannheim. It is the national hub of Europe's largest public-privatepartnership in the detection and validation of innovative academic research results and entrepreneurial capacity in the field of health and health care. More than 150 partners from big-pharma, nutritional and consumer care businesses, IT and med-tech companies, public higher education and research organization form a sustainable partnership under the umbrella of the European Institute for Innovation and Technology. EIT-Health will offer access to international entrepreneurship courses for young life scientists and will offer a one-day workshop on the transfer of results all along the value chain. Additionally two ESRs will be offered short stay visits (max 3 months each) in the Heidelberg offices to learn the business perspective on technology transfer.

https://eithealth.eu/

 

 

Sense About Science (SAS): With a database of over 6,000 scientists, from Nobel prize winners to postdocs and PhD students, SAS work in partnership with scientific bodies, research publishers, policy makers, the public and the media, to change public discussions about science and evidence. Their growing international Voice of Young Science network engages hundreds of early career researchers in public debates about research and evidence. SAS activities and publications are used and shaped by community groups, civic bodies, patient organizations, information services, writers, publishers, educators, health services and many others. SAS will offer offered short stay visits (max 3 months each) in the London offices to learn the pleiotropic activities related to public outreach of scientific results.

http://senseaboutscience.org/